Page results
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Information about our UCLH Charity, charity funds and associated charities.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.
-
UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
Having proton beam therapy under general anaesthetic: information for children aged 5-8 patient information
-
Having proton beam therapy under general anaesthetic: information for children aged 1- 4 patient information.
-
Having originally studied classics, and having first worked in publishing and in the British Library, I became a lawyer and spent ten years in commercial litigation practice in the City.
File results
-
FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes
-
FOI/2024/0371 - Acute myeloid leukaemia treatment
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0376 - Advice provided on topical medication for eczema patients
-
FOI/2024/0380 - Appraisal review/ Responsible Officer/ Revalidation Officer
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0393 - Translation service/ communication spend